Peptides / Exenatide
Exenatide
(Byetta, Bydureon)T1glp1clinical
Biomarker Effects
No biomarker data available yet.
Dosing & Pharmacokinetics
Typical Dose0.01 mg
Frequencydaily
Routeclinician-directed
Half-Life9.4 hr
Safety & Evidence
Exenatide is a GLP-1 receptor agonist. Available as Byetta (twice daily) and Bydureon (once weekly). Side effects include nausea and hypoglycemia when combined with sulfonylureas.
Sources
Track Exenatide precisely in the Vivy app.
Your precision instrument awaits.
Download Vivy